MultiCell Technologies Competitors and Similar CompaniesClear all

MultiCell Technologies's competitors and similar companies include Epirium Bio, Alexion Pharmaceuticals and UNITY Biotechnology.

	MultiCell Technologies MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer.	Epirium Bio Epirium Bio is a company that develops therapeutics designed to promote mitochondrial biogenesis and function.	Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.	UNITY Biotechnology Unity Biotechnology designs therapeutics that prevent various diseases of aging.
Founding Date	Founding Date 1962	Founding Date 2008	Founding Date 1992	Founding Date 2009
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations Woonsocket, US HQ	Locations San Diego, US HQ San Diego, US	Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more	Locations South San Francisco, US HQ
Employees	Employees 2	Employees 14	Employees 10,6006% increase	Employees 98
Valuation ($)	Valuation ($) 1 m	Valuation ($) N/A	Valuation ($) 40.3 b	Valuation ($) 23.6 m
Financial
Revenue (est.)	Revenue (est.) $49.3k (FY, 2014)	Revenue (est.) N/A	Revenue (est.) $6.1b (FY, 2020)	Revenue (est.) N/A
Net income	Net income ($528.8k) (FY, 2014)	Net income N/A	Net income $603.4m (FY, 2020)	Net income ($26m) (FY, 2024)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 85m	Total funding raised N/A	Total funding raised $ 210.6m